I’m happy to be back. Agree the management has been terrible, but it was only a year ago (i remember around April 2019) the share price was hovering around $1-$1.10 and everyone on this forum was understandably pretty down.
and then by October-November it was back into the low 3s. Without any real announcements (besides of course RT assuring us a ROW deal was imminent).
It also just takes time for the CR to wash through. It happens with every biotech.
only just over 12 months for a readout on phase 3 so happy to hold
Ann: Completion of Share Purchase Plan, page-24
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |